Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (228) 228
life sciences & biomedicine (214) 214
humans (187) 187
hepatitis c (136) 136
hepatitis c virus (135) 135
male (114) 114
hepatitis (113) 113
female (111) 111
adult (99) 99
infectious diseases (96) 96
gastroenterology & hepatology (81) 81
health aspects (77) 77
middle aged (63) 63
substance abuse (62) 62
substance abuse, intravenous - complications (62) 62
virus diseases (62) 62
infections (61) 61
antiviral agents - therapeutic use (59) 59
hepatitis c - drug therapy (58) 58
hepatitis c - epidemiology (57) 57
hepacivirus - genetics (52) 52
drugs (48) 48
analysis (47) 47
hcv (47) 47
drug abuse (46) 46
drug use (46) 46
hepatitis c - virology (43) 43
drug therapy (42) 42
genotype (42) 42
interferon (41) 41
people who inject drugs (40) 40
virology (40) 40
immunology (38) 38
human immunodeficiency virus--hiv (37) 37
medical research (37) 37
young adult (37) 37
risk factors (36) 36
hiv (33) 33
antiviral agents (32) 32
medical treatment (32) 32
medicine, experimental (32) 32
treatment (32) 32
microbiology (31) 31
viruses (30) 30
biological and medical sciences (29) 29
medical sciences (29) 29
prospective studies (29) 29
public health (29) 29
treatment outcome (29) 29
care and treatment (28) 28
hepatitis c - diagnosis (28) 28
hepatitis c, chronic - drug therapy (28) 28
opioids (28) 28
pwid (28) 28
viral diseases (28) 28
drug users (27) 27
cohort studies (26) 26
hepatitis c - complications (26) 26
hepatitis c - prevention & control (26) 26
epidemiology (25) 25
substance abuse, intravenous - epidemiology (25) 25
australia (24) 24
hepacivirus (24) 24
human viral diseases (24) 24
psychiatry (23) 23
injecting drug use (22) 22
prevalence (22) 22
prevention (22) 22
research (22) 22
viral hepatitis (22) 22
hepatitis c - transmission (21) 21
intravenous drug addicts (21) 21
liver diseases (21) 21
treatment programs (21) 21
digestive system diseases (20) 20
gastroenterology and hepatology (20) 20
injections (20) 20
internal medicine (20) 20
biological response modifiers (19) 19
incidence (19) 19
narcotics (19) 19
recurrence (19) 19
ribavirin - therapeutic use (19) 19
viral load (19) 19
antiviral agents - administration & dosage (18) 18
medical education (18) 18
rna (18) 18
abridged index medicus (17) 17
australia - epidemiology (17) 17
rna, viral - blood (17) 17
hiv infections - epidemiology (16) 16
systematic review (16) 16
drug addiction (15) 15
hepacivirus - isolation & purification (15) 15
hepatitis c, chronic - virology (15) 15
hiv infections - complications (15) 15
interferon-alpha - therapeutic use (15) 15
liver (15) 15
mortality (15) 15
phylogeny (15) 15
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Epidemiology and natural history of HCV infection
by Hajarizadeh, Behzad and Grebely, Jason and Dore, Gregory J
Nature reviews. Gastroenterology & hepatology, ISSN 1759-5045, 09/2013, Volume 10, Issue 9, pp. 553 - 562
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Morbidity - trends | Global Health | Humans | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Hepatitis C, Chronic - epidemiology | DNA, Viral - genetics | Disease Progression | Causes of | Genetic aspects | Research | Hepatitis C | Epidemiology | Distribution | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Restrictions for medicaid reimbursement of sofosbuvir for the treatment of hepatitis C virus infection in the United States
by Barua, Soumitri and Greenwald, Robert and Grebely, Jason and Dore, Gregory J and Swan, Tracy and Taylor, Lynn E
Annals of internal medicine, ISSN 0003-4819, 08/2015, Volume 163, Issue 3, pp. 215 - 223
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Drug Costs | Insurance, Health, Reimbursement | Medicaid - economics | Antiviral Agents - therapeutic use | United States | Humans | Uridine Monophosphate - economics | Hepatitis C, Chronic - drug therapy | Uridine Monophosphate - analogs & derivatives | Antiviral Agents - economics | Eligibility Determination | Health Policy | Sofosbuvir | Uridine Monophosphate - therapeutic use | Care and treatment | Medicaid | Hepatitis C | Analysis | Drugs | Hepatitis | Infections | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Direct-Acting antiviral agents for HCV infection affecting people who inject drugs
by Grebely, Jason and Hajarizadeh, Behzad and Dore, Gregory J
Nature reviews. Gastroenterology & hepatology, ISSN 1759-5045, 11/2017, Volume 14, Issue 11, pp. 641 - 651
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Hepatitis C - psychology | Substance Abuse, Intravenous | Hepatitis C - drug therapy | Antiviral Agents - therapeutic use | Humans | Drugs | Antiviral agents | Opioids | Clinical trials | Chronic infection | Infections | Interferon | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Can hepatitis C virus infection be eradicated in people who inject drugs?
by Grebely, Jason and Dore, Gregory J
Antiviral research, ISSN 0166-3542, 04/2014, Volume 104, Issue 1, pp. 62 - 72
Drug users | Treatment as prevention | HCV | IDUs | Injection | PWID | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Virology | Antiviral agents | Drug addiction | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Viral diseases | Biological and medical sciences | Medical sciences | Viral hepatitis | Infectious diseases | Pharmacology. Drug treatments | Psychopathology. Psychiatry | Addictive behaviors | Human viral diseases | Antibiotics. Antiinfectious agents. Antiparasitic agents | Global Health | Hepatitis C - drug therapy | Antiviral Agents - therapeutic use | Humans | Seroepidemiologic Studies | Antibodies, Viral - blood | Substance-Related Disorders - complications | Substance-Related Disorders - epidemiology | Cost-Benefit Analysis | Hepatitis C - epidemiology | Geography, Medical | Hepatitis C - complications | Hepatitis C - prevention & control | Hepacivirus | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression
by Waziry, Reem and Hajarizadeh, Behzad and Grebely, Jason and Amin, Janaki and Law, Matthew and Danta, Mark and George, Jacob and Dore, Gregory J
Journal of hepatology, ISSN 0168-8278, 12/2017, Volume 67, Issue 6, pp. 1204 - 1212
Recurrence | Hepatocellular carcinoma | Chronic hepatitis C virus | Occurrence | Epidemiology | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Liver Neoplasms - virology | Antiviral Agents - therapeutic use | Humans | Middle Aged | Male | Risk | Carcinoma, Hepatocellular - virology | Interferons - therapeutic use | Hepatitis C, Chronic - complications | Hepatitis C, Chronic - drug therapy | Liver Neoplasms - etiology | Female | Aged | Carcinoma, Hepatocellular - etiology | Liver cancer | Hepatitis | Cirrhosis | Interferon | Hepatitis C | Antiviral drugs | Patients | Risk factors | Meta-analysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Prevention, treatment and care of hepatitis C virus infection among people who inject drugs
by Bruggmann, Philip and Grebely, Jason
The International journal of drug policy, ISSN 0955-3959, 2015, Volume 26, Issue 1, pp. S22 - S26
Internal Medicine | Medical Education | Hepatitis C | PWID | Life Sciences & Biomedicine | Substance Abuse | Science & Technology | Drug Costs | Needle-Exchange Programs - organization & administration | Prevalence | Hepatitis C - drug therapy | Antiviral Agents - therapeutic use | Humans | Cost of Illness | Hepatitis C - economics | Health Services Accessibility | Antiviral Agents - adverse effects | Harm Reduction | Hepatitis C - epidemiology | Opiate Substitution Treatment - methods | Health Policy | Hepatitis C - prevention & control | Substance Abuse, Intravenous - complications | Virus diseases | Antiviral agents | Health care reform | Biological response modifiers | Drug therapy | Hepatitis C virus | Health aspects | Disease prevention | Hepatitis | Antiretroviral drugs | Injections | Human immunodeficiency virus--HIV | Health care access | Public health | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Breaking Down the Barriers to Hepatitis C Virus (HCV) Treatment Among Individuals With HCV/HIV Coinfection: Action Required at the System, Provider, and Patient Levels
by Jason Grebely and Megan Oser and Lynn E. Taylor and Gregory J. Dore
The Journal of infectious diseases, ISSN 0022-1899, 3/2013, Volume 207, Issue 1, pp. S19 - S25
hepatitis C virus | human immunodeficiency virus | treatment | barriers | coinfection | drug users | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | HIV Infections - prevention & control | Hepatitis C - drug therapy | Antiviral Agents - therapeutic use | Coinfection - drug therapy | Coinfection - prevention & control | Humans | Infection Control - methods | Hepatitis C - diagnosis | HIV Infections - diagnosis | HIV Infections - complications | Coinfection - diagnosis | HIV Infections - drug therapy | Hepatitis C - complications | Hepatitis C - prevention & control | Substance Abuse, Intravenous - complications | Index Medicus | Abridged Index Medicus | Hepatitis C Virus-HIV Co-Infection
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights